vimarsana.com

Latest Breaking News On - Applied markets group - Page 1 : vimarsana.com

Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results

Full-year outlook revised to reflect slower market recovery Announces plan to repurchase $0.75 billion of its common stock by end of fiscal year Board of directors authorizes new $2.0 billion share.

Padraig mcdonnellSecurities exchangeGenomics groupAgilent life sciencesAgilent technologies incLife sciencesExchange commissionAgilent crosslab groupAgilent technologiesApplied marketsApplied markets groupEarnings conferenceAgilent investor relationsSecurities exchange actTax cutsJobs act

Agilent Technologies : Second Quarter 2024 Prepared Remarks

Agilent Technologies Second Quarter Fiscal 2024 Conference Call Prepared Remarks Parmeet Ahuja, Vice President, Investor Relations .

Phil binnsSimon mayBob mcmahonAngelica riemannParmeet ahujaPadraig mcdonnellAsia paciAgilent crosslab groupGenomics groupLife sciencesAgilent life sciencesAgilent technologies second quarter fiscalVice presidentInvestor relationsApplied markets groupAgilent diagnostics

Agilent to Report Q2 Earnings: What s in the Offing? - Agilent Technologies (NYSE:A), Broadcom (NASDAQ:AVGO)

Agilent Technologies (NYSE: A) is set to report its second-quarter fiscal 2024 results on May 29.

Dell technologiesDell technologieAgilent technologiesAgilent life sciences applied markets groupNucleic acid solutions divisionAgilent cross lab groupAgilent technologies incGenomics groupZacks consensus estimateCross lab groupLife sciencesApplied markets groupAdvanced materialsZacks rankStrong buy

Agilent Technologies Inc (A) Faces Headwinds: Q1 Fiscal 2024 Earnings Analysis

Revenue Declines Amidst Market Challenges, Maintains Full-Year Outlook

Mike mcmullenAgilent technologies incDiagnostics researchAgilent crosslab groupGenomics groupAgilent life sciencesSegment performanceLife sciencesApplied markets groupMedical diagnosticsBalance sheetMarket challenges

Agilent Reports First-Quarter Fiscal Year 2024 Financial Results

Revenue and earnings exceed Q1 guidance Full-year outlook maintained Highlights Revenue of $1.66 billion, down 5.6% reported and 6.4% core from the first quarter of 2023. GAAP net income of.

Mike mcmullenGenomics groupSecurities exchangeAgilent crosslab groupAgilent life sciencesAgilent technologiesLife sciencesAgilent technologies incExchange commissionApplied marketsApplied markets groupEarnings conferenceAgilent investor relationsSecurities exchange actTax cutsJobs act

vimarsana © 2020. All Rights Reserved.